CardioTech International Inc. announced Wednesday that it is preparing for European clinical trials of its patented CardioPass Coronary Artery Bypass Graft. Woburn-based CardioTech has been developing ...

CardioTech International Inc. reported a 1 percent increase in revenue and a 55 percent narrowing of its net loss for the nine-month period ending December 31 when compared with the same nine months ...

WOBURN, Mass.-CardioTech International Inc. has completed the first phase of testing on its CardioPass synthetic coronary artery bypass graft, a product it claims has a potential market of $1.5 ...

Medical devices maker CardioTech International Inc. plans to acquire Gish Biomedical Inc. for about $7.6 million in stock. The move significantly will expand Woburn, Mass.-based CardioTech's presence ...

A tripling in sales during the last fiscal year has spurred CardioTech International Inc. into expanding a major portion of its four-division, three-plant operation. The urethane medical device maker ...

CardioTech's clinical end points are patient survivability, quality of life, freedom from angina, and graft patency. Dr. Michael Szycher, CEO and Chairman, CardioTech, said, "The Company is embarking ...

Co anoounces it it has signed an agreement to sell its Gish Biomedical subsidiary in a stock transaction to Medos Medizintechnik AG for a purchase price of approx $7.5 mln. Of the purchase price, $1.0 ...

Medical device manufacturer CardioTech International Inc. has bought a plastics-oriented contract manufacturer, CarTika Medical Inc., for $6.6 million. Publicly traded CardioTech of Wilmington, Mass., ...

CardioTech International may well become known as the pride of Wilmington. Headquartered in Wilmington, the company develops and markets medical devices used in the treatment of late stage ...

CardioTech International Inc., a medical device developer and manufacturer, acquired Plymouth-based CarTika Medical Inc., a privately held medical device contract manufacturer. Terms of the deal were ...